Financhill
Back

Verve Therapeutics Vs. 10x Genomics Industry Stock Comparison

Sell
36

VERV
Verve Therapeutics

Last Price:
5.60
Seasonality Move:
-34.1%
Sell
33

TXG
10x Genomics

Last Price:
21.55
Seasonality Move:
3.95%
Sell
36
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics a Buy, Sell or Hold?

  • The current Verve Therapeutics [VERV] share price is $5.60. The Score for VERV is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
10x Genomics (TXG) is a Sell

Is 10x Genomics a Buy, Sell or Hold?

  • The current 10x Genomics [TXG] share price is $21.55. The Score for TXG is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • TXG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VERV Stock Price Chart

What is Verve Therapeutics's stock price today?

  • The Verve Therapeutics share price today is $5.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.

TXG Stock Price Chart

What is 10x Genomics's stock price today?

  • The 10x Genomics share price today is $21.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TXG is experiencing selling pressure, which indicates risk of future bearish movement.

VERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.86 Sell
Chaikin Money Flow: 756028 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.75 - 6.03) Buy
Bollinger Bands (100): (5.07 - 6.69) Sell

TXG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.69 Buy
Relative Strength Index (14 RSI): 49.08 Sell
Chaikin Money Flow: -840207 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.84 - 23.2) Buy
Bollinger Bands (100): (18.84 - 25.62) Sell

VERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.94 Sell
20-day SMA: 5.26 Buy
50-day SMA: 5.93 Sell
200-day SMA: 9.27 Sell
8-day EMA: 5.76 Sell
20-day EMA: 5.65 Sell
50-day EMA: 5.86 Sell
200-day EMA: 8.84 Sell

TXG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.71 Sell
20-day SMA: 22.2 Sell
50-day SMA: 20.14 Buy
200-day SMA: 33.42 Sell
8-day EMA: 22.57 Sell
20-day EMA: 22.05 Sell
50-day EMA: 21.61 Sell
200-day EMA: 30.23 Sell

Verve Therapeutics Earnings Growth & VERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.

10x Genomics Earnings Growth & TXG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.28 per share, an increase this year of $0.17 per share, and an increase next year of $0.30 per share.

Verve Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

10x Genomics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):